Cocrystal Pharma Inc (COCP)
1.77
+0.06
(+3.51%)
USD |
NASDAQ |
Sep 27, 16:00
1.74
-0.03
(-1.69%)
After-Hours: 20:00
Cocrystal Pharma Cash from Operations (Quarterly): -3.699M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -3.699M |
| March 31, 2024 | -4.503M |
| December 31, 2023 | -3.326M |
| September 30, 2023 | -2.681M |
| June 30, 2023 | -5.548M |
| March 31, 2023 | -3.111M |
| December 31, 2022 | -4.893M |
| September 30, 2022 | -8.908M |
| June 30, 2022 | -3.724M |
| March 31, 2022 | -3.91M |
| December 31, 2021 | -2.922M |
| September 30, 2021 | -5.403M |
| June 30, 2021 | -2.624M |
| March 31, 2021 | -1.77M |
| December 31, 2020 | -2.381M |
| September 30, 2020 | -3.061M |
| June 30, 2020 | -2.20M |
| March 31, 2020 | -2.188M |
| December 31, 2019 | -1.23M |
| September 30, 2019 | -1.323M |
| June 30, 2019 | -1.028M |
| March 31, 2019 | 2.018M |
| December 31, 2018 | -1.97M |
| September 30, 2018 | -2.149M |
| June 30, 2018 | -2.093M |
| Date | Value |
|---|---|
| March 31, 2018 | -2.078M |
| December 31, 2017 | -1.58M |
| September 30, 2017 | -2.186M |
| June 30, 2017 | -1.085M |
| March 31, 2017 | -2.052M |
| December 31, 2016 | -2.301M |
| September 30, 2016 | -3.146M |
| June 30, 2016 | -5.166M |
| March 31, 2016 | -4.042M |
| December 31, 2015 | -3.04M |
| September 30, 2015 | -3.187M |
| June 30, 2015 | -2.531M |
| March 31, 2015 | -1.559M |
| December 31, 2014 | -1.755M |
| September 30, 2014 | -1.139M |
| June 30, 2014 | -1.338M |
| March 31, 2014 | -1.78M |
| December 31, 2013 | -0.808M |
| September 30, 2013 | -0.948M |
| June 30, 2013 | -0.978M |
| March 31, 2013 | -0.952M |
| December 31, 2012 | 0.0479M |
| September 30, 2012 | 0.401M |
| June 30, 2012 | -0.1021M |
| March 31, 2012 | -1.936M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-8.908M
Minimum
Sep 2022
-1.23M
Maximum
Dec 2019
-3.470M
Average
-3.086M
Median
Cash from Operations (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -8.902M |
| Alaunos Therapeutics Inc | -1.681M |
| Oragenics Inc | -1.544M |
| Cara Therapeutics Inc | -12.44M |
| Jaguar Health Inc | -8.17M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | -14.28M |
| Free Cash Flow Per Share (Quarterly) | -0.3636 |
| Free Cash Flow Yield | -79.23% |